Welcome to our dedicated page for Univ Health Svc news (Ticker: UHS), a resource for investors and traders seeking the latest updates and insights on Univ Health Svc stock.
Universal Health Services, Inc. reports developments tied to its hospital and healthcare-services operations through subsidiaries that operate acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points in the United States, the United Kingdom and Puerto Rico. Recurring news includes quarterly and annual financial results, operating outlooks, earnings-call schedules and presentations at healthcare conferences.
Company updates also cover capital-allocation and financing actions, including cash dividends, share repurchases, credit-agreement changes and other material corporate events. News about UHS commonly links operating performance to its acute care and behavioral health platforms, as well as governance and shareholder communication matters.
Universal Health Services (NYSE: UHS) reported net income attributable to UHS of $445.9M in Q4 2025 ($7.06 diluted EPS) and $1.489B for full-year 2025 ($23.10 diluted EPS). Net revenues rose 9.1% in Q4 to $4.486B and 9.7% for 2025 to $17.365B. Adjusted EBITDA net of NCI was $678.7M in Q4 and $2.590B for 2025. 2026 guidance: net revenues $18.417B–$18.789B, Adjusted EBITDA $2.641B–$2.789B, EPS-diluted $22.64–$24.52, capex $950M–$1.1B.
Cash from operations was $1.864B in 2025 (down $203M YoY). Share repurchases in 2025 totaled 4.65M shares for ~$899.3M; available buyback authorization approx. $1.425B.
Universal Health Services (NYSE: UHS) will present at three March 2026 healthcare conferences with scheduled dates and times.
Presentations: March 3, 2026 at 11:50am ET (TD Cowen), March 9, 2026 at 8:00am ET (Leerink Partners), and March 10, 2026 at 11:00am ET (Barclays). A live audio webcast and replay will be available on the Company investor relations website.
Universal Health Services (NYSE: UHS) announced a cash dividend of $0.20 per share, payable on March 16, 2026 to shareholders of record as of March 2, 2026.
The company operates acute care hospitals, behavioral health facilities, outpatient centers and ambulatory access points across the United States, Puerto Rico and the United Kingdom.
Universal Health Services (NYSE: UHS) will release fourth-quarter 2025 results for the period ended December 31, 2025, after market close on Wednesday, February 25, 2026. A conference call for investors and analysts is scheduled at 9:00 a.m. ET on Thursday, February 26, 2026.
A live webcast will be available on the company's website and telephone participation requires advance registration; a replay will be available for one year.
Acadia Healthcare (NASDAQ: ACHC) appointed Debra K. Osteen as Chief Executive Officer and added her to the Board, effective immediately, with Chris Hunter departing the company and its Board. The Board said it will conduct a comprehensive search for a long-term successor while Osteen leads the company. The company reaffirms its full-year 2025 guidance, expecting revenue $3.28B–$3.30B, Adjusted EBITDA $601M–$611M, and adjusted EPS $1.94–$2.04. Management previously reiterated guidance at the J.P. Morgan Healthcare Conference on January 13, 2026. The company noted it cannot reconcile projected Adjusted EBITDA and adjusted EPS to GAAP due to unknown transaction-related expenses and their tax effects.
Universal Health Services (NYSE: UHS) announced its Board of Directors approved a cash dividend of $0.20 per share. The dividend is payable on December 15, 2025 to shareholders of record as of December 1, 2025.
UHS operates acute care hospitals, behavioral health facilities, outpatient centers and ambulatory access points across the United States, Puerto Rico and the United Kingdom.
Universal Health Services (NYSE: UHS) will present at the Wolfe Research Healthcare Conference 2025 in New York on Wednesday, November 19, 2025 at 8:00 a.m. EST.
A live audio webcast and a replay will be available via the company’s Investor Relations website at www.uhsinc.com. Universal Health Services operates acute care hospitals, behavioral health facilities and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.
Universal Health Services (NYSE: UHS) reported strong third-quarter 2025 results and raised full-year guidance on October 27, 2025. Q3 net income attributable to UHS was $373.0 million ($5.86 diluted) and net revenues rose 13.4% to $4.495 billion. Adjusted Q3 EBITDA net of NCI was $670.6 million. For the first nine months, net income was $1.043 billion and net revenues were $12.879 billion, up 9.9% year-over-year. The Board authorized a $1.5 billion increase to the stock repurchase program, bringing available authorization to $1.759 billion.
The company raised its 2025 revised forecast to $17.306–$17.445B net revenues and Adjusted EPS $21.50–$22.10, citing operating trends and a new Washington, D.C. Medicaid payment program.
Universal Health Services (NYSE: UHS) will report third-quarter results for the period ended September 30, 2025 after the market close on Monday, October 27, 2025. A conference call for investors and analysts is scheduled for 9:00 a.m. ET on Tuesday, October 28, 2025 and will be accessible via a live webcast on the company's website at www.uhs.com. Telephone participation requires advance registration; registrants receive a confirmation email with dial-in details, a unique passcode, and registrant ID. A replay of the call will be available for one year following the live event. The company operates acute care hospitals, behavioral health facilities and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.
Universal Health Services (NYSE: UHS), a leading healthcare services provider, has appointed Darren Lehrich as Vice President of Investor Relations, reporting to CFO Steve Filton. Lehrich brings extensive experience from his previous roles, including CFO at Help at Home and investor relations leadership positions at Magellan Health and American Renal Associates.
Prior to his corporate roles, Lehrich spent 17 years as an equity research analyst, including serving as managing director at Deutsche Bank from 2005-2015. He holds a Bachelor's degree in Health Policy and Administration from Penn State and an MBA in Finance from Purdue University.